An open-label study of nelotanserin in patients with Lewy body dementia who have frequent visual hallucinations or REM sleep behaviors
Jared Brosch, MD
Primary Investigator
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to evaluate the long-term safety of the study drug nelotanserin and to assess the effects of nelotanserin in subjects experiencing frequent visual hallucination and/or REM sleep behavior disorders due to dementia with Lewy bodies.
Description
The purpose of this study is to evaluate the long-term safety of the study drug nelotanserin and to assess the effects of nelotanserin in subjects experiencing frequent visual hallucination and/or REM sleep behavior disorders due to dementia with Lewy bodies.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
dementia with Lewy bodies
-
Age: - 100 Years
-
Gender: All